Hutchinson-Gilford Progeria Syndrome: Clinical and Molecular Characterization
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in The Application of Clinical Genetics
- Vol. 13, 159-164
- https://doi.org/10.2147/TACG.S238715
Abstract
Hutchinson-Gilford progeria syndrome (HGPS) is a rare congenital disease caused by mutations in the LMNA gene. Children with HGPS are phenotypically characterized by lipodystrophy, short height, low body weight, scleroderma, reduced joint mobility, osteolysis, senile facial features, and cardiovascular compromise that usually lead to death. We aimed to describe the case of a patient who reached above-average age expectancy for children with HGPS in Latin America and describe the clinical and molecular characteristics of the patient. A 14-year-old female patient was presented with progeria-compatible phenotypic characteristics. HGPS was confirmed via LMNA gene sequencing that detected a heterozygous c.1824C>T (p. Gly608Gly) mutation. The primary aim is to describe the HGPS case, the molecular gene mutation finding, and make a short review of the limited available treatment options for children with HGPS. Such as the farnesyl transferase inhibitors in conjunction with other pharmacological therapies that have insinuated improvement in health, and survival rate.This publication has 26 references indexed in Scilit:
- The epidemiology of premature aging and associated comorbiditiesClinical Interventions in Aging, 2013
- Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–Gilford progeria syndromeProceedings of the National Academy of Sciences of the United States of America, 2012
- Phenotype and Course of Hutchinson–Gilford Progeria SyndromeThe New England Journal of Medicine, 2008
- New Approaches to ProgeriaPEDIATRICS, 2007
- Disease Progression in Hutchinson-Gilford Progeria Syndrome: Impact on Growth and DevelopmentPEDIATRICS, 2007
- Hutchinson–Gilford progeria syndrome: Review of the phenotypeAmerican Journal of Medical Genetics Part A, 2006
- Prelamin A and lamin A appear to be dispensable in the nuclear laminaJCI Insight, 2006
- Somatic and gonadal mosaicism in Hutchinson–Gilford progeriaAmerican Journal of Medical Genetics Part A, 2005
- Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndromeNature, 2003
- The Hutchinson-Gilford progeria syndrome: Report of 4 cases and review of the literatureThe Journal of Pediatrics, 1972